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Abstract 
Background: Prevention and surveillance programs are key to contain Nosocomial Infections (Nis). At the European Institute of 
Oncology, surveillance based on ex-post data collection has been done since the inception of hospital activity; laboratory-based 
surveillance of microbiological alert was not standardized. This study describes the issues related to the recent introduction into the 
hospital routine of a laboratory-based automated surveillance system and its clinical impact on monitoring and treatment of Nis. 
Methods: An interdisciplinary team defined the alerts and the actions to be taken in response; recipients of the alert messages were 
identified and software was programmed. Program features were created so their employment would generate a prompt notification of 
clinically critical results. After a training period, the program was introduced in the hospital routine. 
Results: There were a total of 150 generated alerts; the main alert related to microorganisms requiring prompt patient isolation and/or 
public notification. Clinical use of the program was relevant in detection and immediate notification of Cytomegalovirus active infection 
in stem cell recipients and central venous catheter related candidemia: the prompt administration of adequate treatment was possible 
hours earlier compared to the previous approach. 
Conclusions:  A laboratory-based automated surveillance system is effective in facilitating the management of Nis; its clinical 
employment also leads to important clinical advantages in patient care.
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Introduction 
Nosocomial Infections (Nis) represent a great challenge for 
hospital personnel as a significant cause of increased mortality 
and morbidity in hospitalized patients, as well as increased 
costs of health-care systems; such that their rate is a 
recognized indicator of quality of care and safety [1,2]. Social-
economic and human impact of Nis can be limited by 
implementing strict prevention actions and active surveillance 
programs [3]. Appropriate staff education, close adherence to 
guidelines and established procedures, in addition to continuous 
training, are the foundation of all effective preventive programs 
[4,5].Currently, surveillance programs are based on the 
monitoring of clinically relevant infections through regular data 
collection and analysis, which allows the evaluation of local 
incidence of infections and their trends in comparison with 
retrospective data, as well as to identify outbreaks and risk 
factors and finally, to compare one’s rates with the literature 
and/or other institutions’ data. In addition to this periodical 
monitoring through time, a continuous and timely laboratory-
based surveillance assures a prompt identification of sentinel 
events according to standard requirements [6–8]. The 
surveillance activity traditionally is performed through the 
manual review of computerized reports; this methodology 
however is labour-intensive and neither assures a sensitive 
detection of sentinel events/outbreaks nor a rapid intervention 
by infection control professionals; in fact, only the use of an 
automated system for Nis control, can provide an accurate and 
real-time surveillance at a lower cost [9,10]. Over the last few 
years, various electronic Nis surveillance systems have been 
developed which extract data from the database of microbiology 
laboratory, clinical wards, pharmacy and admission-transfer-
discharge and identify abnormal events and/or microorganism 
distribution compared to the standard procedure. 
The aim of this article was to describe the issues regarding the 
implementation of a laboratory-based automated system, 
recently introduced in the hospital routine, which was able to 
identify microbiological alerts and to notify in real-time the 
involved professionals. We also analyse its clinical impact on 
the surveillance and treatment of Nis. 
Methods 
This study was prospectively carried out at the European 
Institute of Oncology (IEO) in Milan, a 226 inpatient-bed 
comprehensive cancer centre, operating since 1994 in cancer 
prevention, diagnosis, research and treatment. It includes two 
medical divisions (Medical Oncology and Haemato-Oncology), 
eight divisions of oncological surgery and a four-bed Intensive 
Care Unit (ICU). 
At the time we implemented the automated system, the 
surveillance programs of major Nis had been continuously run 
at IEO by the application of standardized criteria, addressing: (i) 
category of infection to be monitored (ventilator-associated 
pneumonia, nosocomial pneumonia, central line-associated 
bloodstream infections, surgical site infections of selected 
surgical procedures and catheter-related urinary tract 
infections); (ii) data collection frequency (once a month); (iii) 
data collection sources (from microbiology laboratory reports, 
surgical wards and operating room databases, pharmacy and 
clinical records); (iv) data analysis and emission of reports by 
ICC (Infections Control Committee). 
Our objective was to introduce a standardized method for 
microbiological alert surveillance and notification; thus in 2006, 
a computerized system for the identification of predefined 
sentinel events and their notification to clinicians, Chief Medical 
Office (CMO) and ICC members was implemented and 
introduced in the hospital routine. 
The alert system developed initially involved the Microbiology 
Laboratory, Abdomino-Pelvic Surgery Division (APSD) and ICU. 
The software Virtuoso Plus
TM (Metafora Informatica Srl, Milano, 
Italy) has been used, which was able to extract the data directly 
from the laboratory software and to elaborate the findings. 
The early stage of the implementation of the new system was to 
identify sentinel events. An alert list, based on national and 
international scientific societies guidelines and 
recommendations [11], was determined by an interdisciplinary 
team who integrated these suggestions with IEO specific 
demands; thus in addition to universally accepted alerts 
(Methicillin–resistant Staphylococcus aureus (MRSA), 
Vancomycin-resistant Enterococci (VRE), multi-drug resistant P. 
aeruginosa, etc), we added some events critical in our Institute, 
among which were, for example, Aspergillus species found in 
respiratory tract samples (IEO was in the progress of building 
renovation) [12–14]. To satisfy Nis control, according to the 
Centers for Diseases Control guidelines, ISS (Istituto Superiore 
di Sanità, corresponding to NIH-USA) and Regione Lombardia 
recommendations and IEO specific procedures, a list of actions 
to be taken in response to each event was issued, including 
what to do to contain the risk of transmission and how to 
proceed to notify the CMO and the local Healthcare Authority, 
when needed (Table 1). 
Table 1: List of alerts and actions to be taken 
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Legend: CMO, Chief Medical Office; ASL, Azienda Sanitaria Locale (the local Healthcare Authority) 
Table 2: Example of alerts extraction criteria with the software Virtuoso Plus 
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Legend: ICC, Infections Control Committee. 
Chief of Microbiology Laboratory, Epidemiology Nurse, 
Directors and Chief Nurses of the involved Divisions, CMO and 
ICC Operating Group were identified as recipients of the alert 
messages. The software setting proceeded: for each identified 
alert the extraction criteria were defined, including the strain of 
bacteria isolated, type of clinical sample, patients and divisions 
involved, recipients of messages and extraction time planning 
(Table 2). 
A standardized alert message, containing a description of the 
alert event, patient’s data, division of admission, sample 
examined and microbiological results, has been created to be 
automatically sent by email to the above recipients. At the same 
time, a list of all extracted alerts in the current session, with the 
indication of admission ward, was automatically generated and 
stored in a directory on the central server, available for 
evaluation by ICC members: this report allows the location of 
the contemporary presence of the same event in different 
patients, thus providing a tool to search for a common infection 
source (e.g. the same operating room or ICU stay). The 
extraction of alerts was planned once a day for the routine tests 
and every two hours for the tests needed urgently. 
Due to the possibility of personalization, we resolved to also use 
this software for a prompt notification to the clinicians of 
clinically critical results, such as the growth of S.  aureus or 
Candida species in blood cultures or Cytomegalovirus and/or 
Herpes viruses genome detection in clinical samples after 
hematopoietic stem cell transplantation [15–17] among the 
others; we entered these alerts identifying, however, only the 
clinicians as message recipient. 
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After a ten-month training period, involving only APSD and ICU, 
specifically dedicated to software validation and evaluation of 
technical functionality, we obtained a positive feedback of its 
employment and we decided to introduce this surveillance 
method in the hospital routine. To ensure its correct use by all 
operators, a new institutional procedure entitled ‘Management 
of the Microbiological Alerts’ was issued, and the program with 
its clinical relevance was presented to clinical directors and 
chief nurses (who in turn showed it to all the nursing staff); 
some posters to affix in each division, listing alerts and actions 
to be performed, were also distributed. 
Results 
From May 2006 to September 2008, 150 alert notifications were 
generated from samples sent to the laboratory for 
microbiological analysis. Table 3 shows these alerts with 
pertinent data and actions taken. 
Multi-drug resistant P. aeruginosa, S. maltophilia, extended-
spectrum beta-lactamase (ESBL) and MRSA claimed the 
infected patients to be promptly placed in contact isolation in 
order to reduce the risk of direct or indirect transmission [18]. In 
particular, from January 2008 a significant increase of MRSA 
was detected, so, in addition to the isolation of patients, we 
planned some refresher courses on the isolation procedures for 
professionals, and a survey of our patients colonization at the 
time of admission and discharge. Mycobacteria and 
Salmonella related alerts led to both the isolation of patients 
and to public notification. With regard to the clinical employment 
of the program, C. albicans strains were isolated from a central 
and a peripheral blood culture in two patients, with a Differential 
Time to Positivity [19,20] proving a catheter-related bloodstream 
infection, thus forcing clinicians to immediately remove the 
device. The growths of S. aureus in blood culture were not 
CVC-related. CMV genome found in three stem cell recipient 
patients led clinicians to start or change the antiviral therapy. 
 
Discussion 
At the IEO, since the beginning of hospital activity, an Infections 
Control Committee has ensured Nis surveillance through the 
review and approval of surveillance and prevention programs, 
the analysis of Nis collected data and identification of 
interventional areas, the assessment and promotion of better 
practices and staff training in infection control, the infectious risk 
assessment of new technologies and finally the communication 
and cooperation with external ICC for audit activities. 
A rapid detection of microbiological alerts is also crucial for 
effective control of nosocomial outbreaks, of both common and 
unusual micro-organisms, and micro-organisms with unusual 
phenotypical traits (such as multi-drug resistance). Detection of 
these outbreaks by clinical evaluation is difficult, so it is usually 
found on periodic reports ex-post laboratory collected data, 
which is a fairly slow method and is late in outbreak detection. 
A laboratory-based management of Nis control, on the contrary, 
allows the rapid survey of alerts; the electronic notification (by 
email) to the involved divisions ensures, on the other hand, a 
real-time receipt of the alert messages, thus facilitating the 
prompt accomplishment of actions required to find the cause, 
and the immediate implementation of effective measures to 
contain the risk and to treat infected patients. This was all 
accomplished following procedures and guidelines previously 
shared by all the staff. Only the use of an automated system 
made this surveillance method possible. 
In the past, the survey of microbiological alerts at IEO was in 
the care of Microbiology Laboratory staff, without a standardized 
method; so, the implementation of an automated surveillance 
system is shown as a very positive choice, both for the 
standardization of alert extraction criteria and for the well-timed 
data reporting to clinicians, with evident advantages: in the case 
of infectious agents requiring the isolation of patients, for 
example, the reduction in time of alerts communication reduced 
the risk of patient-to-patient transmission of microorganisms. 
The immediate effect is a clinical advantage for the patients and 
the possibility for the hospital staff to monitor longitudinally the 
infectious epidemiological setting. The real-time communication 
of unusual data to division professionals and ICC members, 
moreover, ensures their continuous knowledge of the Nis 
current status. In the instances of infections requiring a public 
notification, this surveillance system allows an automated and 
documented—by email—notification of relevant data as 
requested by the Italian Health Care System, including patient 
anagraphical data, the isolated microorganisms, the date of the 
sampling and of the report, and finally the ward of admission. 
In our experience, major advantages of this software are related 
to the capability to personalize the extraction criteria: with 
careful preliminary selection work, both the alerts and the 
notification’s message recipients can be modified from time to 
time, according to the hospital needs. A major feature is the 
possibility of providing a message relevant for clinical use, 
allowing an immediate implementation of all needed therapeutic 
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Table 3: Number of generated alerts and related clinical samples; in bold, clinically critical events 
 
Legend: CMO, Chief Medical Office; ASL, Azienda Sanitaria Locale (the local Healthcare Authority) 
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actions and a real-time feedback of pertinent information in 
doubtful cases, so leading to important benefits in patient care: 
in the CVC-related candidemia, for example, clinicians, promptly 
alerted, could remove the device and start the correct therapy 
hours in advance compared to the previous approach, thus 
decreasing the risk of severe complications connected to this 
infection [21]; also the immediate signalling to clinicians of CMV 
genome detection in stem cell recipients allowed the adjustment 
of treatment without further delay [22]. 
Finally, the implementation of this system can lead to further 
results over time, not less significant than the clinical benefits 
already detected, but related to the educational value of this
approach: regular and prompt notification of critical issues to all 
health-care staff will enhance their awareness for clinically 
relevant Nis, thus improving a safe environment. 
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